These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32209694)

  • 41. Contribution of pertussis toxin to the pathogenesis of pertussis disease.
    Carbonetti NH
    Pathog Dis; 2015 Nov; 73(8):ftv073. PubMed ID: 26394801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BspR/BtrA, an Anti-σ Factor, Regulates the Ability of
    Nakamura K; Shinoda N; Hiramatsu Y; Ohnishi S; Kamitani S; Ogura Y; Hayashi T; Horiguchi Y
    mSphere; 2019 Apr; 4(2):. PubMed ID: 31019000
    [No Abstract]   [Full Text] [Related]  

  • 43. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y; Sato H; Chazono M; Ginnaga A; Tamura C
    Dev Biol Stand; 1991; 73():93-107. PubMed ID: 1778339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A commentary on the pathogenesis of pertussis.
    Hewlett EL
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S94-8. PubMed ID: 10447025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice.
    Goodwin MS; Weiss AA
    Infect Immun; 1990 Oct; 58(10):3445-7. PubMed ID: 2401570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphisms influencing expression of dermonecrotic toxin in Bordetella bronchiseptica.
    Okada K; Abe H; Ike F; Ogura Y; Hayashi T; Fukui-Miyazaki A; Nakamura K; Shinzawa N; Horiguchi Y
    PLoS One; 2015; 10(2):e0116604. PubMed ID: 25642712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Albumin, in the Presence of Calcium, Elicits a Massive Increase in Extracellular Bordetella Adenylate Cyclase Toxin.
    Gonyar LA; Gray MC; Christianson GJ; Mehrad B; Hewlett EL
    Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of lymphocytosis-promoting factor from Bordetella pertussis on cerebellar cyclic GMP levels.
    Askelöf P; Gillenius P
    Infect Immun; 1982 Jun; 36(3):958-61. PubMed ID: 6284647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion.
    Mouallem M; Farfel Z; Hanski E
    Infect Immun; 1990 Nov; 58(11):3759-64. PubMed ID: 2172167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis.
    Bassinet L; Gueirard P; Maitre B; Housset B; Gounon P; Guiso N
    Infect Immun; 2000 Apr; 68(4):1934-41. PubMed ID: 10722585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenylate cyclase toxin from Bordetella pertussis: current concepts and problems in the study of toxin functions.
    Hewlett EL; Kim KJ; Lee SJ; Gray MC
    Int J Med Microbiol; 2000 Oct; 290(4-5):333-5. PubMed ID: 11111907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating pertussis toxin and its impact on vaccination.
    Coutte L; Locht C
    Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.
    Fry NK; Neal S; Harrison TG; Miller E; Matthews R; George RC
    Infect Immun; 2001 Sep; 69(9):5520-8. PubMed ID: 11500425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunobiologic activity of Bordetella pertussis strains defective in various virulence factors].
    Smirnov VD; Chuprinina RP; Siundiukova RA; Maksiutov RV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):8-10. PubMed ID: 2545060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Demonstration of differential virulence gene promoter activation in vivo in Bordetella pertussis using RIVET.
    Veal-Carr WL; Stibitz S
    Mol Microbiol; 2005 Feb; 55(3):788-98. PubMed ID: 15661004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.
    Carbonetti NH; Artamonova GV; Andreasen C; Dudley E; Mays RM; Worthington ZE
    Infect Immun; 2004 Jun; 72(6):3350-8. PubMed ID: 15155640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allele frequencies of Bordetella pertussis virulence-associated genes identified from pediatric patients with severe respiratory infections.
    Imamura T; Shoji K; Kono N; Kubota M; Nishimura N; Ishiguro A; Miyairi I
    J Infect Chemother; 2020 Jul; 26(7):765-768. PubMed ID: 32334951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of pertussis toxin in causing symptoms of Bordetella parapertussis infection.
    Wirsing von König CH; Finger H
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):455-8. PubMed ID: 7957264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Internalization of Bordetella pertussis adenylate cyclase-haemolysin into endocytic vesicles contributes to macrophage cytotoxicity.
    Khelef N; Gounon P; Guiso N
    Cell Microbiol; 2001 Nov; 3(11):721-30. PubMed ID: 11696032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pathological effect of the Bordetella dermonecrotic toxin in mice.
    Magyar T; Glávits R; Pullinger GD; Lax AJ
    Acta Vet Hung; 2000; 48(4):397-406. PubMed ID: 11402657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.